RHO and cancer: In addition to E-cadherin downregulation, Twist1 may contribute to the development of a motile mesenchymal-like cancer cell phenotype through the activation of RAC1 (Ras-related C3 botulinum toxin substrate 1), a small G-protein of the Rho family [25].